FDA Warning Letter — Anicare Pharmaceuticals Pvt Ltd.

Case 569251 — FEI 3007450508

The FDA took a Warning Letter action against Anicare Pharmaceuticals Pvt Ltd. on February 28, 2019 (Navi Mumbai, India). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
Anicare Pharmaceuticals Pvt Ltd.
Date
February 28, 2019
Fiscal Year
2019
Product Type
Drugs
Center
CDER
Location
Navi Mumbai (India)